Concepedia

Elisabetta Bolli

EB

Statistics

Publications

14

Citations

507

H-Index

12

Active since

2011

Affiliations

University of Turin(Current)

University of Chieti-Pescara

University of Parma

Istituti di Ricovero e Cura a Carattere Scientifico

Elisabetta Bolli is an author at University of Turin specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

2011–2023

14

Publications

14

Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer

Stefania Lanzardo, Laura Conti, Ronald Rooke et al. · Cancer Research · 2015 · 128 citations · Full text

, , +17

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer<i>in vivo</i>

Elisabetta Bolli, John P. O’Rourke, Laura Conti et al. · OncoImmunology · 2017 · 62 citations · Full text

, , +17

Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells

Gaetano Donofrío, Giulia Tebaldi, Stefania Lanzardo et al. · OncoImmunology · 2018 · 49 citations · Full text

, , +14

Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

Laura Conti, Elisabetta Bolli, Antonino Di Lorenzo et al. · Cancer Immunology Research · 2020 · 42 citations · Full text

, , +17

Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy

Antonino Di Lorenzo, Elisabetta Bolli, Roberto Ruiu et al. · OncoImmunology · 2022 · 38 citations · Full text

, , +16

1–5 of 14